Enforcement record
承認取消及び業務改善命令 disclosure naming 小林化工株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
承認取消及び業務改善命令
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
28 April 2021
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Completed archive verified
- Captured: Jul 12, 2026, 03:33 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Open the official source links in the section below to review the original disclosure.
Action summary
- Company
- 小林化工株式会社Japanese onlyOriginal: 小林化工株式会社
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices医薬品医療機器等法
- Action type
- 承認取消及び業務改善命令承認取消及び業務改善命令
- Action date
- 28 April 2021
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品製造業
Violation
The Ministry of Health, Labour and Welfare has today issued an administrative disposition to Kobayashi Kako Co., Ltd., including approval cancellation based on Article 74-2, Paragraph 3, Item 2 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, and a business improvement order based on Article 72-4, Paragraph 1 of the same Act, as detailed in the attached document.
Show original Japanese text
厚生労働省では、本日付で、小林化工株式会社に対し別紙の通り、医薬品医療機器等法第74条の2第3項第2号の規定に基づく承認取消及び同法第72条の4第1項に基づく業務改善命令(行政処分)を行いましたので、お知らせします。
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive
- Extracted at
- 2026-04-24T23:36:21.54+00:00
- Evidence checked
- 2026-04-24T23:36:21.54+00:00
- Archive captured
- 2026-07-12T06:33:33.491052+00:00
Show audit JSON
{
"record": {
"id": "7893ba64-10e4-47ec-9e40-95f17f27edbd",
"url": "https://regbase.jp/en/enforcement/other-xiao-lin-hua-gong-20210428",
"company_name_original": "小林化工株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "医薬品医療機器等法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "承認取消及び業務改善命令",
"en": "承認取消及び業務改善命令"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (小林化工株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-xiao-lin-hua-gong-20210428",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_18351.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/dcd5dac040hf0hg1",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_18351.html",
"archiveCapturedAt": "2026-07-12T06:33:33.491052+00:00",
"extractedAt": "2026-04-24T23:36:21.54+00:00",
"translatedAt": "2026-05-01T06:51:11.307+00:00",
"evidenceCheckedAt": "2026-04-24T23:36:21.54+00:00",
"generatedAt": "2026-09-21T16:03:49.132Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.